Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TUBGCP3 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-08 |
mRNA | RASGEF1B | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-08 |
mRNA | ZNF33A | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-08 |
mRNA | PSMD12 | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-08 |
mRNA | ZNF227 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-08 |
mRNA | HDLBP | CTRPv2 | pan-cancer | AAC | -0.18 | 8e-08 |
mRNA | FXYD6 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-08 |
mRNA | BOLA3 | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-08 |
mRNA | SHC2 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-08 |
mRNA | SREBF2 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-08 |